Related Experiment Video
Updated: May 31, 2026
13:18
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Neuroprotective Kaurane Diterpenes from Fritillaria ebeiensis
Jing Xu1, Ping Guo, Cuizhou Liu
1College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
Bioscience, Biotechnology, and Biochemistry
|July 9, 2011
Summary
Researchers discovered a new kaurane diterpene from Fritillaria ebeiensis bulbs. This compound and others isolated showed significant neuroprotective effects in lab studies.
Area of Science:
- Natural Products Chemistry
- Neuropharmacology
- Medicinal Chemistry
Background:
- Fritillaria ebeiensis is a plant species known for its traditional medicinal uses.
- Diterpenes are a class of natural compounds with diverse biological activities.
- Neurodegenerative diseases, such as Parkinson's disease, are characterized by dopaminergic neuronal loss.
Purpose of the Study:
- To isolate and characterize new and known kaurane diterpenes from Fritillaria ebeiensis bulbs.
- To evaluate the neuroprotective potential of these isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation using extensive spectroscopic analyses including IR, ESI-MS, HR-ESI-MS, 1-D and 2-D NMR.
- Assessment of neuroprotective effects using an in vitro model of dopaminergic neurodegeneration (MPP(+)-induced cell death in SH-SY5Y cells).
Main Results:
- A new kaurane diterpene, ent-3β-butanoyloxykaur-15-en-17-ol, was identified.
- Four known kaurane diterpenes were also isolated and characterized.
- All isolated kaurane diterpenes demonstrated neuroprotective activity against MPP(+)-induced neuronal cell death.
Conclusions:
- Fritillaria ebeiensis bulbs are a source of kaurane diterpenes with neuroprotective properties.
- The identified compounds, particularly the new diterpene, hold potential for further investigation as therapeutic agents for neurodegenerative diseases.
